Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis
Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis
复制标题
DOI:
10.1152/ajpgi.00444.2007
复制
发表时间:
2008-01-01
影响因子:
4.5
通讯作者:
Rosenbaum, Jean
中科院分区:
文献类型:
--
作者:
Rullier, Anne;Gillibert-Duplantier, Jennifer;Rosenbaum, Jean
Thrombin inhibition protects against liver fibrosis. However, it is not known whether the thrombin profibrogenic effect is due to effects on blood coagulation or to signaling via protease-activated receptors (PARs). We took advantage of the lack of blood coagulation defects in PAR-1-knockout mice. Acute carbon tetrachloride (CCl4) toxicity was similar in wildtype (WT), PAR-1(-/-), and PAR-1(+/-) mice as judged by aminotransferase levels, area of liver necrosis, and liver peroxidation measured by Fourier-transformed infrared spectroscopy. Fifteen mice/group received CCl4 or its solvent for 6 wk (300 mu l/kg, 3 times a week). Fibrosis area was increased 10-fold by CCl4 treatment in WT mice. PAR-1 deficiency protected against fibrosis, with 36% and 56% decrease in PAR-1(+/-) and PAR-1(-/-) mice, respectively (P < 0.001). Similar results were obtained for area of activated fibrogenic cells (64% and 79% decrease in PAR-1(+/-) and PAR-1(-/-) mice, respectively, P < 0.001). These findings were corroborated by measurements of type I collagen, matrix metalloproteinase-2, and PDGF-beta receptor mRNA levels. There was also a significant decrease in T lymphocyte infiltration in PAR-1-deficient mice. Altogether, these results suggest that thrombin profibrogenic effects are independent of effects on blood coagulation and are instead due to direct effects on fibrogenic cells and possibly on T lymphocytes.